Hydroxychloroquine treatment of patients with human immunodeficiency virus type 1
- 31 August 1995
- journal article
- clinical trial
- Published by Elsevier BV in Clinical Therapeutics
- Vol. 17 (4), 622-636
- https://doi.org/10.1016/0149-2918(95)80039-5
Abstract
No abstract availableKeywords
This publication has 48 references indexed in Scilit:
- Increased interleukin 6 concentrations in the absence and presence of HIV-1 infection in haemophilia.Journal of Clinical Pathology, 1992
- Restoration of immunoglobulin secretion in vitro in common variable immunodeficiency by in vivo treatment with polyethylene glycol-conjugated human recombinant interleukin-2Clinical Immunology and Immunopathology, 1992
- Once-Daily Administration of 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- 2′,3′-Dideoxyinosine (ddI) in Patients with the Acquired Immunodeficiency Syndrome or AIDS-Related ComplexNew England Journal of Medicine, 1990
- Mitochondrial Myopathy Caused by Long-Term Zidovudine TherapyNew England Journal of Medicine, 1990
- Zidovudine in Asymptomatic Human Immunodeficiency Virus InfectionNew England Journal of Medicine, 1990
- Quantitation of Human Immunodeficiency Virus Type 1 in the Blood of Infected PersonsNew England Journal of Medicine, 1989
- The Toxicity of Azidothymidine (AZT) in the Treatment of Patients with AIDS and AIDS-Related ComplexNew England Journal of Medicine, 1987
- Antibody Response to Preexposure Human Diploid-Cell Rabies Vaccine Given Concurrently with ChloroquineNew England Journal of Medicine, 1986
- Action of chloroquine phosphate in rheumatoid arthritis. 1. Immunosuppressive effect.Annals Of The Rheumatic Diseases, 1973